SINOPHARM GROUP CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.6 HKD | +3.35% |
|
+10.54% | +5.62% |
| Apr. 16 | Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets | MT |
| Apr. 10 | Chinese FDA Grants Marketing Approval for Shyndec Subsidiary's Drug Raw Materials | MT |
| Sales 2023 | 597B 82.34B 645B | Sales 2024 * | 650B 89.71B 702B | Capitalization | 62.36B 8.61B 67.4B |
|---|---|---|---|---|---|
| Net income 2023 | 9.05B 1.25B 9.79B | Net income 2024 * | 9.86B 1.36B 10.65B | EV / Sales 2023 | 0.1 x |
| Net Debt 2023 * | 16.56B 2.29B 17.89B | Net Debt 2024 * | 3.53B 488M 3.82B | EV / Sales 2024 * | 0.1 x |
| P/E ratio 2023 |
6.41
x | P/E ratio 2024 * |
6.33
x | Employees | 115,959 |
| Yield 2023 * |
4.29% | Yield 2024 * |
4.83% | Free-Float | 42.99% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | +3.35% | ||
| 1 week | +10.54% | ||
| Current month | +7.73% | ||
| 1 month | +4.60% | ||
| 3 months | +17.01% | ||
| 6 months | +9.76% | ||
| Current year | +5.62% |
1 week
19.06
22.10
1 month
19.0622.10
Current year
17.4423.00
1 year
17.4428.45
3 years
14.6028.45
5 years
14.6031.90
10 years
14.6045.65
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Liu
PSD | President | 55 | 09-01-08 |
Shuang Jun Xu
PRN | Corporate Officer/Principal | 55 | 11-02-28 |
Zhong Xi Cai
PRN | Corporate Officer/Principal | 59 | 10-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
BRD | Director/Board Member | 52 | 10-04-30 |
Xiao Hui Guan
BRD | Director/Board Member | 53 | 19-01-10 |
Yi Jian Wu
SEC | Corporate Secretary | 54 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.58% | 4 M€ | -27.92% | ||
| 1.36% | 2 M€ | -19.10% | - | |
| 0.48% | 4 M€ | -11.56% | ||
| 0.47% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 21.6 | +3.35% | 7,496,349 |
| 24-04-23 | 20.9 | -0.48% | 2,854,571 |
| 24-04-22 | 21 | +5.63% | 7,177,727 |
| 24-04-19 | 19.88 | +0.51% | 5,116,540 |
| 24-04-18 | 19.78 | -0.30% | 7,331,359 |
Delayed Quote Hong Kong S.E., April 24, 2024 at 04:08 am EDT
More quotes
Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.
Sector
Pharmaceuticals
Calendar
2024-04-25
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
19.98
CNY
Average target price
25.06
CNY
Spread / Average Target
+25.42%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +5.62% | 8.32B | |
| +15.65% | 69.91B | |
| +2.72% | 25.14B | |
| +6.10% | 8.07B | |
| -21.85% | 7.97B | |
| +0.73% | 4.56B | |
| +17.40% | 4.31B | |
| -0.14% | 3.99B | |
| -2.34% | 3.87B | |
| +21.03% | 3.63B |
- Stock Market
- Equities
- 1099 Stock
